Free Trial

25,418 Shares in STERIS plc (NYSE:STE) Purchased by Global Assets Advisory LLC

STERIS logo with Medical background

Global Assets Advisory LLC bought a new position in shares of STERIS plc (NYSE:STE - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 25,418 shares of the medical equipment provider's stock, valued at approximately $5,714,000.

A number of other large investors also recently modified their holdings of STE. VisionPoint Advisory Group LLC acquired a new stake in shares of STERIS in the 4th quarter worth about $34,000. Pingora Partners LLC acquired a new position in shares of STERIS during the fourth quarter worth approximately $37,000. Glassman Wealth Services bought a new position in STERIS in the 4th quarter worth approximately $38,000. Spire Wealth Management increased its position in STERIS by 88.0% in the 4th quarter. Spire Wealth Management now owns 203 shares of the medical equipment provider's stock valued at $45,000 after acquiring an additional 95 shares during the period. Finally, AdvisorNet Financial Inc boosted its position in STERIS by 144.9% during the 4th quarter. AdvisorNet Financial Inc now owns 311 shares of the medical equipment provider's stock worth $68,000 after acquiring an additional 184 shares during the period. 94.69% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other STERIS news, VP Renato Tamaro sold 1,154 shares of the firm's stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $231.64, for a total transaction of $267,312.56. Following the completion of the transaction, the vice president now owns 6,677 shares in the company, valued at $1,546,660.28. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, VP Renato Tamaro sold 1,154 shares of the firm's stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $231.64, for a total transaction of $267,312.56. Following the completion of the sale, the vice president now owns 6,677 shares of the company's stock, valued at $1,546,660.28. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Cary L. Majors sold 2,024 shares of the business's stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $232.13, for a total value of $469,831.12. Following the completion of the transaction, the senior vice president now directly owns 11,369 shares in the company, valued at $2,639,085.97. The disclosure for this sale can be found here. Insiders have sold 7,762 shares of company stock worth $1,798,477 over the last 90 days. Corporate insiders own 1.14% of the company's stock.


Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. StockNews.com upgraded shares of STERIS from a "hold" rating to a "buy" rating in a research note on Saturday, June 15th. Piper Sandler reaffirmed a "neutral" rating and issued a $225.00 price target (up previously from $220.00) on shares of STERIS in a report on Friday, May 10th. JMP Securities reiterated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a report on Thursday, May 9th. Finally, Needham & Company LLC restated a "hold" rating on shares of STERIS in a report on Friday, May 10th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $241.60.

Get Our Latest Analysis on STE

STERIS Stock Performance

Shares of STE stock traded down $1.10 during trading hours on Tuesday, reaching $215.46. 282,731 shares of the company's stock were exchanged, compared to its average volume of 494,894. STERIS plc has a fifty-two week low of $195.47 and a fifty-two week high of $254.00. The company has a quick ratio of 2.36, a current ratio of 3.08 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $21.30 billion, a P/E ratio of 56.69 and a beta of 0.85. The business has a fifty day moving average price of $218.73 and a 200-day moving average price of $220.78.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.41 by $0.17. STERIS had a net margin of 6.95% and a return on equity of 13.73%. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the previous year, the firm posted $2.30 EPS. The business's revenue was up 10.8% compared to the same quarter last year. Analysts predict that STERIS plc will post 9.24 EPS for the current fiscal year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be given a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, June 12th. This represents a $2.08 annualized dividend and a yield of 0.97%. STERIS's dividend payout ratio (DPR) is currently 54.45%.

About STERIS

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Recommended Stories

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Should you invest $1,000 in STERIS right now?

Before you consider STERIS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.

While STERIS currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

CPI News Breakdown: Key Market Moves to Follow
Understanding Oversold Stocks
Inside Pelosi’s Latest Stock Moves

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines